Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6804390> ?p ?o }
Showing triples 1 to 30 of
30
with 100 triples per page.
- Q6804390 subject Q6585501.
- Q6804390 subject Q7336348.
- Q6804390 subject Q7404119.
- Q6804390 abstract "Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in children with severe primary IGF-I deficiency.This drug is not to be confused with mecasermin rinfabate (trade name Iplex), which is a combination of recombinant human IGF-1 (rhIGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3). IGFBP-3 serves to prolong the action of IGF-1 in the human body.".
- Q6804390 atcPrefix "H01".
- Q6804390 atcSuffix "AC03".
- Q6804390 casNumber "68562-41-4".
- Q6804390 drugbank "DB01277".
- Q6804390 fdaUniiCode "7GR9I2683O".
- Q6804390 wikiPageWikiLink Q14863714.
- Q6804390 wikiPageWikiLink Q1497481.
- Q6804390 wikiPageWikiLink Q18027678.
- Q6804390 wikiPageWikiLink Q285697.
- Q6804390 wikiPageWikiLink Q6585501.
- Q6804390 wikiPageWikiLink Q6804391.
- Q6804390 wikiPageWikiLink Q7336348.
- Q6804390 wikiPageWikiLink Q7404119.
- Q6804390 wikiPageWikiLink Q824258.
- Q6804390 atcPrefix "H01".
- Q6804390 atcSuffix "AC03".
- Q6804390 casNumber "68562".
- Q6804390 drugbank "DB01277".
- Q6804390 unii "7".
- Q6804390 type ChemicalSubstance.
- Q6804390 type Drug.
- Q6804390 type ChemicalObject.
- Q6804390 type Thing.
- Q6804390 type Q8386.
- Q6804390 comment "Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in children with severe primary IGF-I deficiency.This drug is not to be confused with mecasermin rinfabate (trade name Iplex), which is a combination of recombinant human IGF-1 (rhIGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3). IGFBP-3 serves to prolong the action of IGF-1 in the human body.".
- Q6804390 label "Mecasermin".